Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

NCT: NCT03706027 · RECRUITING

NCT IDNCT03706027
StatusRECRUITING
Start Date2018-12-15
Completion2034-11-15
SponsorUniversity of Rochester (OTHER)
First posted
Last updated

Brief Summary

This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatment, they will follow up with their radiation oncologist.

Frequently Asked Questions

What is Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer?

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer is a clinical trial registered under NCT03706027. Current status: RECRUITING.

What is the status of NCT03706027?

The current status of NCT03706027 (Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer) is: RECRUITING.

When did Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer start?

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer started on 2018-12-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.